Elena Madan, MD
Anesthesiology · Los Angeles, CANPI 1154985901
Payments from drug & device makers
Across 85 payments — averaging $96.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$2K
- Abbott$381
- SPR Therapeutics, Inc$374
- Nevro Corp.$189
- Avanos Medical$160
- plus $559 from 9 others
What the payments were for
- Travel & lodging$5,08362%
- Food & beverage$3,10238%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 37 | $4,313 |
| Boston Scientific | 16 | $2,210 |
| Abbott | 8 | $381 |
| SPR Therapeutics, Inc | 2 | $374 |
| Nevro Corp. | 4 | $189 |
| Avanos Medical | 2 | $160 |
| Saluda Medical Americas, Inc. | 2 | $148 |
| Nalu Medical, Inc. | 4 | $114 |
| Vertos Medical, Inc. | 1 | $101 |
| Relievant Medsystems, Inc. | 3 | $48 |
| Tersera Therapeutics LLC | 2 | $43 |
| Bioventus LLC | 1 | $33 |
| AbbVie | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Curonix LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,737
- KYPHON EXPRESS II KYPHOPAK TRAY$726
- VANTA ADAPTIVESTIM$418
- SPRINT PNS System$374
- ETERNA$291
- SYNCHROMEDII$167
- GENERATOR$156
- Evoke SCS$137
- WaveWriter Alpha Prime 16$133
- mild Device Kit$101
How this compares
$8,186 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $533 |
| Oxycodone Hcl | 13 | $421 |
| Gabapentin | 17 | $165 |
| Tramadol Hcl | 16 | $156 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Los Angeles
- Eilon GabelLos Angeles$1.2M
- Maxime CannessonLos Angeles$759K
- Moody MakarLos Angeles$252K
- Jonathan JahrLos Angeles$223K
- Anahat DhillonLos Angeles$184K
- Michael BottrosLos Angeles$182K
- David BoldtLos Angeles$153K
- Kamal MaheshwariSacramento$1.9M
- Gregory HammerStanford$1.8M
- Neal FlemingSacramento$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.